Subject 2: Scan 2(b) (6/14/2003)

Fig. 2-b. Second bone density scan (Achilles Ultrasonometer) of subject 2 (female, age 56 years) taken two months after completing 4 month safety evaluation period (6 months after first scan). Results indicated a significant increase in BMD, from 69% to 75% (yellow highlighted area).

All contents Copyright © 2008 Tango Advanced Nutrition, Inc. All rights reserved. AllerPhase®, ArthriPhase™, BronchoPhase®, CardioPhase®, Daily Movement™, FemmePhase®, Herbal Boost™, ImmunoPhase®, MetaPhase®, OsteoPhase®, PriaPlex®, Pure Tango®, SleepCycle™, Tango® and Vital Cell® are registered trademarks of Tango Advanced Nutrition, Inc. The content provided by this site is for informational purposes only and has not been approved by the U.S. FDA. This site is not intended to provide personal medical advice, which should be obtained from a medical professional.